Can a Pre-Surgery boost help cancer patients recover faster?
NCT ID NCT06275737
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests an 8-week program of nutrition advice, exercise, and psychological support for people with pancreatic or esophageal cancer before they have surgery. The goal is to see if patients can complete the program and if it helps them prepare for surgery. Only 9 patients are enrolled, so this is a very early look at whether this approach is feasible.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Prehabilitation program (nutritional, psychological, and personalized physical activity interventions)
- What this could lead to
- If successful, this program could help patients feel stronger and recover better after surgery for pancreatic or esophageal cancer.
- What could go wrong
- This is a very small, early feasibility study with only 9 participants, so results may not apply to everyone. The program requires significant effort and may not be suitable for all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CENTRE HOSPITALIER UNIVERSITAIRE ROUEN - CHU Charles Nicolle
Rouen, France
-
CHU de Reims
Reims, France
-
Centre Hospitalier Universitaire Dijon Bourgogne
Dijon, France
-
Centre Hospitalier Universitaire Tours - Hopital Trousseau
Tours, France
-
Centre Hospitalier Universitaire de Lille
Lille, France
-
Groupe hospitalier Rance Emeraude (CHU Saint-Malo)
St-Malo, France
-
Hospital La Timone
Marseille, France
-
INSTITUT CURIE de SAint Cloud
Saint-Cloud, France
-
Institut Daniel Hollard - Groupe Hospitalier Mutualiste de Grenoble
Grenoble, France
-
Institut de Cancerologie de L'Ouest Rene Gauducheau
Saint-Herblain, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can pancreatic Cancer's inflammatory footprint be stopped?
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Blood and gut clues may flag pancreatic cancer risk early
- A high-tech camera may take the guesswork out of spotting a dangerous surgery complication
- Blood test score may flag High-Risk esophageal surgery patients
- Can a new drug combo shrink Hard-to-Treat tumors?